Protein tyrosine phosphatase 1B reduction regulates adiposity and expression of genes involved in lipogenesis

Cristina M Rondinone1, James M Trevillyan, Jill Clampit

  • 1Metabolic Diseases Research, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, Illinois 60064, USA. cristina.rondinone@abbott.com

Diabetes
|July 30, 2002
PubMed

Insights

Targeting protein tyrosine phosphatase 1B (PTP1B) with antisense therapy reduced fat storage and lipogenesis in obese mice. This suggests PTP1B plays a key role in obesity development and adipocyte enlargement.

Area of Science:

  • Biochemistry
  • Metabolic disease research
  • Obesity research

Background:

  • Protein tyrosine phosphatase 1B (PTP1B) is a negative regulator of insulin signaling.
  • PTP1B overexpression is linked to insulin resistance and obesity.
  • PTP1B knockout mice show enhanced insulin sensitivity and resistance to weight gain.

Purpose of the Study:

  • To investigate the role of PTP1B in adipose tissue of obese animals.
  • To assess the effects of PTP1B antisense oligonucleotide (ISIS-113715) treatment on obesity and lipogenesis in hyperglycemic obese (ob/ob) mice.

Main Methods:

  • Hyperglycemic obese (ob/ob) mice were treated with PTP1B antisense oligonucleotide (ISIS-113715).
  • Adiposity, PTP1B protein levels, triglyceride content, and gene expression in adipose tissue were analyzed.
  • Key lipogenic and adipogenic genes, insulin signaling proteins, and protein kinase B phosphorylation were assessed.

Main Results:

  • Antisense treatment significantly reduced adiposity and PTP1B protein levels in fat tissue.
  • Triglyceride content in adipocytes was influenced, with downregulation of lipogenic genes (SREBP1, spot14, FAS).
  • Increased IRS-2 protein and differential regulation of p85alpha isoforms were observed, but insulin sensitivity via Akt phosphorylation was not enhanced.

Conclusions:

  • PTP1B antisense treatment effectively modulates fat storage and lipogenesis in adipose tissue.
  • PTP1B is implicated in adipocyte enlargement and the development of obesity.
  • Targeting PTP1B may offer therapeutic potential for managing obesity and related metabolic disorders.

Related Concept Videos

PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Protein Kinases and Phosphatases02:54

Protein Kinases and Phosphatases

Proteins undergo chemical modifications that trigger changes in the charge, structure, and conformation of the proteins. Phosphorylation, acetylation, glycosylation, nitrosylation, ubiquitination, lipidation, methylation, and proteolysis are various protein modifications that regulate protein activity. Such modifications are usually enzyme-driven.
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
cAMP-dependent Protein Kinase Pathways01:25

cAMP-dependent Protein Kinase Pathways

Cyclic Adenosine Monophosphate (cAMP) is an essential second messenger that activates protein kinase A (PKA) and regulates various biological processes. A single epinephrine molecule binds to GPCR and activates several heterotrimeric G proteins, each stimulating multiple adenylyl cyclase, amplifying the signal, and synthesizing large numbers of cAMP molecules. Small changes in cAMP concentration affect PKA activity. The binding of four cAMP molecules induces a conformational change in PKA,...
Cell Specific Gene Expression01:58

Cell Specific Gene Expression

Multicellular organisms contain a variety of structurally and functionally distinct cell types, but the DNA in all the cells originated from the same parent cells. The differences in the cells can be attributed to the differential gene expression. Liver cells, whose functions include detoxification of blood, production of bile to metabolize fats, and synthesis of proteins essential for metabolism, must express a specific set of genes to perform their functions. Gene expression also varies with...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...